Li Yong, Guo Jianxi, Zhang Yanfang, Kong Jian
Department of Interventional Radiology, Shenzhen People's Hospital (Second Clinical Medical College of Jinan University, First Affiliated Hospital of Southern University of Science and Technology), Shenzhen, China.
J Interv Med. 2021 Dec 9;5(1):15-22. doi: 10.1016/j.jimed.2021.12.002. eCollection 2022 Feb.
Port-A-Cath systems (PCS) are safe and convenient devices for long-term infusion in patients with malignant tumors. This study retrospectively analyzed the complications from PCS and their management.
Data of 1695 adults (641 males and 1054 females) with malignant tumors who underwent PCS implantation in our center from January 1, 2009 to December 31, 2019 who had complete follow-up records were collected in this study. The early and late complications and corresponding treatments were studied.
A total of 1716 PCSs were implanted; 21 patients underwent 2 implantations each. The success rate was 100% and no severe complications occurred during implantation. The overall occurrence rate of post-implantation complications was 18.5% (318/1716); 5.5% (94/1716) were early complications and 13.0% (224/1716) were late complications. A total of 451 PCSs were removed, of which 398 were removed due to the end of chemotherapy, while 53 were removed because of complications. A total of 4 deaths occurred from these complications.
The incidence of intra- and post-operative complications is low. In most cases, complications can be effectively controlled without the removal of the PCS and regular follow-up and maintenance are critical.
输液港系统（PCS）是用于恶性肿瘤患者长期输液的安全便捷装置。本研究回顾性分析了输液港系统的并发症及其处理方法。
收集2009年1月1日至2019年12月31日在本中心接受输液港植入且有完整随访记录的1695例成年恶性肿瘤患者（男性641例，女性1054例）的数据。研究早期和晚期并发症及相应治疗方法。
共植入1716个输液港；21例患者每人接受了2次植入。植入成功率为100%，植入过程中未发生严重并发症。植入后并发症总发生率为18.5%（318/1716）；早期并发症发生率为5.5%（94/1716），晚期并发症发生率为13.0%（224/1716）。共拔除451个输液港，其中398个因化疗结束而拔除，53个因并发症而拔除。这些并发症共导致4例死亡。
手术中和术后并发症发生率较低。在大多数情况下，并发症无需拔除输液港即可得到有效控制，定期随访和维护至关重要。
